Comparison between OM-GA Cu and Copper-T IUCDs.
OM-GA Cu and Copper-T IUCDs were compared in a randomized prospective clinical trial in two-hundred women and followed up for two years. Dysmenorrhea and dyspareunia were more frequent with the Copper-T. Menometrorrhagiae, vaginal discharge and pelvic inflammatory disease were similar with both IUCDs. Two-year pregnancy rate for the OM-GA Cu was 5.4% and 3.2% for the Copper-T. Expulsion rate was 11.9% for the OM-GA Cu and 5.3% for the Copper-T. The OM-GA Cu users had less dysmenorrhea and dyspareunia but a higher expulsion rate compared to the Copper-T.
D000328:Adult; D002986:Clinical Trials as Topic; D004414:Dyspareunia / Q000209:etiology; D005260:Female; D006801:Humans; D007433:Intrauterine Device Expulsion; D007435:Intrauterine Devices, Copper / Q000009:adverse effects; D007973:Leukorrhea / Q000209:etiology; D008599:Menstruation Disturbances / Q000209:etiology; D000292:Pelvic Inflammatory Disease / Q000209:etiology; D011247:Pregnancy; D011446:Prospective Studies; D011897:Random Allocation